In Nashville, the shortest day of the year has 9 hours and 41 minutes of sunlight, while the longest day has 14 hours and 37 minutes. Those five extra hours have a profound impact on circadian rhythm, daily habits and mood, ...
Jan 31, 2022
0
0
Anhedonia and amotivation are common symptoms in patients with schizophrenia, major depressive disorder and bipolar disorder, suggesting the need to explore the underlying behavioral and neural mechanisms in order to facilitate ...
Jan 28, 2022
0
196
Advancements in medical science have allowed the treatment of psychiatric disorders like major depressive disorder (MDD) with functional magnetic resonance imaging neurofeedback (fMRI-NF) training. fMRI-NF training is a type ...
Dec 22, 2021
0
5
Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond ...
Dec 17, 2021
0
16
A group of mental health experts from research, industry, regulatory bodies and with lived experience have proposed new agreed criteria to define the type of depression that current medications and therapies cannot treat ...
Dec 15, 2021
0
6
New details reported in Science Translational Medicine by a team at Vanderbilt University Medical Center shed light on how current antidepressant drugs work and suggest a new drug target in depression.
Dec 3, 2021
0
86
In the largest genetic study of suicide attempts to date, researchers have identified a region of the genome on chromosome 7 containing DNA variations that increase the risk that a person will attempt suicide.
Nov 30, 2021
0
147
A new study led by researchers at UCLA Health has found that cognitive behavioral therapy (CBT-I) prevented major depression, decreasing the likelihood of depression by over 50% as compared to sleep education therapy in adults ...
Nov 24, 2021
0
146
Scientists at Scripps Research, Florida have determined the near-atomic-scale structure of an unusual brain-cell receptor called GPR158, which has been linked to depression and anxiety.
Nov 18, 2021
0
84
Columbia Psychiatry faculty, in partnership with avoMD, a next-gen clinical decision support platform, have developed an interactive smartphone application that provides point-of-care treatment algorithms for major depression.
Oct 21, 2021
0
10
